# Protara Therapeutics, Inc.: Form 8-K, filed Dec 5, 2024

- Company: [Protara Therapeutics, Inc.](/companies/tara.md) (CIK 1359931)
- Form: 8-K
- Filed: 2024-12-05
- Accepted by EDGAR: Dec 5, 2024, 08:45 ET
- Period: 2024-12-05
- Accession: 0001213900-24-105782
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1359931/000121390024105782/ea0223706-8k_protara.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1359931/000121390024105782/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1359931/000121390024105782/ea0223706-8k_protara.htm

Filed Dec 5, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-105782. Last ingested by Listed: Nov 6, 2026, 12:14 ET. No prices; not investment advice.
